At close: December 20 at 4:00:03 PM EST
After hours: December 20 at 7:50:30 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
131,603.00
143,723.00
145,599.00
130,713.00
63,469.00
Operating Income
-131,603.00
-143,723.00
-145,599.00
-130,713.00
-63,469.00
Net Non Operating Interest Income Expense
14,102.00
9,486.00
3,652.00
390.00
57.00
Other Income Expense
--
--
--
--
57.00
Pretax Income
-117,501.00
-134,237.00
-141,947.00
-130,323.00
-63,412.00
Net Income Common Stockholders
-117,501.00
-134,237.00
-141,947.00
-130,323.00
-70,336.00
Diluted NI Available to Com Stockholders
-117,501.00
-134,237.00
-141,947.00
-130,323.00
-70,336.00
Basic EPS
-1.03
-1.77
-2.60
-3.40
-4.15
Diluted EPS
-1.03
-1.77
-2.60
-3.40
-4.15
Basic Average Shares
117,771.11
75,673.08
54,673.57
38,316.27
16,962.40
Diluted Average Shares
117,771.11
75,673.08
54,673.57
38,316.27
16,962.40
Total Operating Income as Reported
-131,603.00
-143,723.00
-145,599.00
-130,713.00
-63,469.00
Total Expenses
131,603.00
143,723.00
145,599.00
130,713.00
63,469.00
Net Income from Continuing & Discontinued Operation
-117,501.00
-134,237.00
-141,947.00
-130,323.00
-63,412.00
Normalized Income
-117,501.00
-134,237.00
-141,947.00
-130,323.00
-63,412.00
Interest Income
14,102.00
9,486.00
3,652.00
390.00
57.00
Net Interest Income
14,102.00
9,486.00
3,652.00
390.00
57.00
EBIT
-131,603.00
-143,723.00
-145,599.00
-130,713.00
-63,469.00
EBITDA
-129,452.00
-141,575.00
-143,447.00
-128,572.00
-62,802.00
Reconciled Depreciation
2,151.00
2,148.00
2,106.00
2,141.00
667.00
Net Income from Continuing Operation Net Minority Interest
-117,501.00
-134,237.00
-141,947.00
-130,323.00
-63,412.00
Normalized EBITDA
-129,452.00
-141,575.00
-143,447.00
-128,572.00
-62,802.00
12/31/2020 - 7/24/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
VRDN Viridian Therapeutics, Inc.
19.03
+1.60%
LRMR Larimar Therapeutics, Inc.
4.0100
+0.75%
FHTX Foghorn Therapeutics Inc.
5.14
+3.21%
EWTX Edgewise Therapeutics, Inc.
30.78
-0.06%
SLNO Soleno Therapeutics, Inc.
45.18
-0.04%
BMEA Biomea Fusion, Inc.
4.2300
+3.68%
STOK Stoke Therapeutics, Inc.
11.68
+3.36%
XLO Xilio Therapeutics, Inc.
1.2800
+36.46%
BCYC Bicycle Therapeutics plc
14.68
-2.13%
BHVN Biohaven Ltd.
36.26
+2.60%